The Yale Liver Research Core Center brings together a multidisciplinary group of 27 independent principal investigators as well as additional professional supporting personnel in the departments of Medicine, Pathology, Pediatrics, Diagnostic Radiology, Laboratory Medicine, Cellular and Molecular Physiology, Human Genetics, and Cell biology at the School of Medicine in order to further the study of liver structure, function and disease. The Center focuses on six major themes: 1) Cellular and molecular biology of the hepatocyte; 2) hepatic transport; 3) hepatic metabolic function; 4) hepatic fibrogenesis; 5) splanchnic hemodynamics; and 6) clinical studies of hepatic disorders. The research activities of the Center are broad and range from fundamental studies of the biology of the hepatocyte to immediate clinical relevancy in the evalution of chronic human liver disease. The principal goals of this Center have been to: 1) stimulate multidisciplinary interactions; 2) provide a rich training environment; 3) foster national and international collaborations; 4) efficiently organize time consuming, more costly techniques and procedures and core facilities for multiple use; 5) to stimulate basic scientists to become more involved in one or more of the Center's areas of research interest; 6) to capitalize on important new research opportunities through pilot feasibility projects, and 7) to create an institutional environment to greatly amplify progress and answer problems in this important area of digestive disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034989-06
Application #
3102079
Study Section
Diabetes and Digestive and Kidney Diseases Special Grants Review Committee (DDK)
Project Start
1984-09-30
Project End
1994-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Lawan, Ahmed; Min, Kisuk; Zhang, Lei et al. (2018) Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance. Diabetes 67:624-635
Franca, Andressa; Filho, Antonio Carlos Melo Lima; Guerra, Mateus T et al. (2018) Effects of endotoxin on type 3 inositol 1,4,5-trisphosphate receptor in human cholangiocytes. Hepatology :
Liu, Chune; Yang, Zhihong; Wu, Jianguo et al. (2018) Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis. Hepatology 67:1768-1783
Brivio, Simone; Cadamuro, Massimiliano; Fabris, Luca et al. (2018) Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr 18:31-50
Cox, Carly S; McKay, Sharen E; Holmbeck, Marissa A et al. (2018) Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling. Cell Metab 28:776-786.e5
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar et al. (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32:4428-4443
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Jakab, Sofia Simona; Garcia-Tsao, Guadalupe (2018) Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol :

Showing the most recent 10 out of 763 publications